Mark G. Lebwohl

Mark G. Lebwohl, M.D.
Education Columbia University
Harvard Medical School

Medical career

Profession dermatologist
Institutions The Mount Sinai Hospital

Mark G. Lebwohl, M.D., is an American dermatologist and author and the Sol and Clara Kest Professor and Chairman of the Department of Dermatology at the Mount Sinai Hospital in New York City. Lebwohl's books include the leading book on dermatologic therapy, Treatment of Skin Disease (ISBN 0323036031), as well as Atlas of the Skin and Systemic Disease (ISBN 044306539X). He has authored more than 400 publications,[1] multiple book chapters and has been named as one of New York Magazine’s “Best Doctors” every year since the inception of the annual list.[2][3]

Biography

Lebwohl graduated from Columbia University in 1974. He earned his medical degree from Harvard Medical School in 1978 and subsequently completed residencies in both internal medicine and dermatology at the Icahn School of Medicine at Mount Sinai. In 1983, he was made Assistant Professor of Dermatology at Mount Sinai. In 1997, he was named Chairman of the Department[1] which, under his leadership, has been at the forefront of the management of psoriasis.[4]

Lebwohl was the first to report the cardiac complications of pseudoxanthoma elasticum, and, additionally, he has developed new techniques for diagnosing the disease.[4] He was also the first to use immunomodulators (imiquimod) to treat preccancerous skin lesions;[5][6] the first to use topical calcineurin inhibitors to treat psoriasis;[7] and the first to identify interactions between topical vitamin D analogues such as calcipotriol and calcitriol with other topical medications and with ultraviolet light.[8][9]

Lebwohl has served as president of the New York Dermatological Society, the Manhattan Dermatologic Society, and the New York State Society of Dermatology, and as chairman of the Dermatology Section of the New York Academy of Medicine. He served as chairman of the Psoriasis Task Force of the American Academy of Dermatology (AAD), and was a member of the Scientific Assembly Council. He chaired the Academy’s summer meeting in 2001 in California and the AAD annual meeting in Washington, D.C. in 2004. He was elected to the Board of Directors of the AAD for 2010-2014. He is the founding editor of Psoriasis Forum and was medical editor of the bulletin of the National Psoriasis Foundation, Psoriasis Advance.[10][11] He is on the editorial board of the Journal of the American Academy of Dermatology and was the editor of the Dermatology Section of Scientific American Medicine, now called ACP Medicine.

Awards and honors

Lebwohl earned Presidential Citations in 2002, 2005 and 2006 from the American Academy of Dermatology. Additional awards include:

Books

Publications

Partial list:

References

  1. 1 2 TheDerm.org – Editorial Board and Advisors
  2. ↑ New York Magazine Best Doctors 2009
  3. ↑ American Registry
  4. 1 2 Aufses, Jr., Arthur H; Barbara Niss (2002). This House of Noble Deeds. NYU Press. pp. 197–198. ISBN 0-8147-0500-6. Retrieved November 2009. Check date values in: |access-date= (help)
  5. ↑ Persaud AN, Shamuelova E, Sherer D, Lou W, Singer G, Cervera C, et al. (2002). "Clinical effect of imiquimod 5% cream in the treatment of actinic keratosis.". J Am Acad Dermatol. 47 (4): 553–6. doi:10.1067/mjd.2002.123492. PMID 12271300.
  6. ↑ Lebwohl M, Dinehart S, Whiting D, Lee PK, Tawfik N, Jorizzo J, et al. (2004). "Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials.". J Am Acad Dermatol. 50 (5): 714–21. doi:10.1016/j.jaad.2003.12.010. PMID 15097955.
  7. ↑ Lebwohl M, Freeman AK, Chapman MS, Feldman SR, Hartle JE, Henning A, et al. (2004). "Tacrolimus ointment is effective for facial and intertriginous psoriasis.". J Am Acad Dermatol. 51 (5): 723–30. doi:10.1016/j.jaad.2004.07.011. PMID 15523350.
  8. ↑ Patel B, Siskin S, Krazmien R, Lebwohl M (1998). "Compatibility of calcipotriene with other topical medications.". J Am Acad Dermatol. 38 (6 Pt 1): 1010–1. doi:10.1016/s0190-9622(98)70171-9. PMID 9632021.
  9. ↑ Lebwohl M, Hecker D, Martinez J, Sapadin A, Patel B (1997). "Interactions between calcipotriene and ultraviolet light.". J Am Acad Dermatol. 37 (1): 93–5. doi:10.1016/s0190-9622(97)70217-2. PMID 9216529.
  10. ↑ WebMD
  11. ↑ Business Week
  12. ↑ British Medical Association Medical Books
  13. ↑ Society of Authors
  14. ↑ http://www.itsan.org/uploads/2Rapaport_Lebwohl_Corticosteroid_Addiction_and_Withdrawal_in_the_Atopic_Red_Burning_Skin_Syndrome.PDF
This article is issued from Wikipedia - version of the 6/30/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.